These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 36995605

  • 1. In Vivo Evaluation of Exon 51 Skipping in hDMD/Dmd-null Mice.
    Sheri N, Yokota T.
    Methods Mol Biol; 2023; 2640():327-336. PubMed ID: 36995605
    [Abstract] [Full Text] [Related]

  • 2. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
    Echigoya Y, Lim KRQ, Trieu N, Bao B, Miskew Nichols B, Vila MC, Novak JS, Hara Y, Lee J, Touznik A, Mamchaoui K, Aoki Y, Takeda S, Nagaraju K, Mouly V, Maruyama R, Duddy W, Yokota T.
    Mol Ther; 2017 Nov 01; 25(11):2561-2572. PubMed ID: 28865998
    [Abstract] [Full Text] [Related]

  • 3. In Vivo Evaluation of Single-Exon and Multiexon Skipping in mdx52 Mice.
    Mizobe Y, Miyatake S, Takizawa H, Hara Y, Yokota T, Nakamura A, Takeda S, Aoki Y.
    Methods Mol Biol; 2018 Nov 01; 1828():275-292. PubMed ID: 30171548
    [Abstract] [Full Text] [Related]

  • 4. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy.
    Miyatake S, Mizobe Y, Takizawa H, Hara Y, Yokota T, Takeda S, Aoki Y.
    Methods Mol Biol; 2018 Nov 01; 1687():123-141. PubMed ID: 29067660
    [Abstract] [Full Text] [Related]

  • 5. In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.
    Maruyama R, Aoki Y, Takeda S, Yokota T.
    Methods Mol Biol; 2018 Nov 01; 1828():365-379. PubMed ID: 30171554
    [Abstract] [Full Text] [Related]

  • 6. Golodirsen for Duchenne muscular dystrophy.
    Anwar S, Yokota T.
    Drugs Today (Barc); 2020 Aug 01; 56(8):491-504. PubMed ID: 33025945
    [Abstract] [Full Text] [Related]

  • 7. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
    Lee JJA, Saito T, Duddy W, Takeda S, Yokota T.
    Methods Mol Biol; 2018 Aug 01; 1828():141-150. PubMed ID: 30171539
    [Abstract] [Full Text] [Related]

  • 8. Antisense Oligonucleotide Treatment in a Humanized Mouse Model of Duchenne Muscular Dystrophy and Highly Sensitive Detection of Dystrophin Using Western Blotting.
    Maruyama R, Yokota T.
    Methods Mol Biol; 2021 Aug 01; 2224():203-214. PubMed ID: 33606217
    [Abstract] [Full Text] [Related]

  • 9. Designing Effective Antisense Oligonucleotides for Exon Skipping.
    Shimo T, Maruyama R, Yokota T.
    Methods Mol Biol; 2018 Aug 01; 1687():143-155. PubMed ID: 29067661
    [Abstract] [Full Text] [Related]

  • 10. Systemic Delivery of Morpholinos to Skip Multiple Exons in a Dog Model of Duchenne Muscular Dystrophy.
    Maruyama R, Echigoya Y, Caluseriu O, Aoki Y, Takeda S, Yokota T.
    Methods Mol Biol; 2017 Aug 01; 1565():201-213. PubMed ID: 28364245
    [Abstract] [Full Text] [Related]

  • 11. Restoring Dystrophin Expression with Exon 44 and 53 Skipping in the DMD Gene in Immortalized Myotubes.
    Echigoya Y, Yokota T.
    Methods Mol Biol; 2023 Aug 01; 2587():125-139. PubMed ID: 36401027
    [Abstract] [Full Text] [Related]

  • 12. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
    Nakamura A, Aoki Y, Tsoumpra M, Yokota T, Takeda S.
    Methods Mol Biol; 2018 Aug 01; 1828():151-163. PubMed ID: 30171540
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates.
    Lim KRQ, Echigoya Y, Nagata T, Kuraoka M, Kobayashi M, Aoki Y, Partridge T, Maruyama R, Takeda S, Yokota T.
    Mol Ther; 2019 Jan 02; 27(1):76-86. PubMed ID: 30448197
    [Abstract] [Full Text] [Related]

  • 17. Exons 45-55 Skipping Using Antisense Oligonucleotides in Immortalized Human DMD Muscle Cells.
    He M, Yokota T.
    Methods Mol Biol; 2023 Jan 02; 2640():313-325. PubMed ID: 36995604
    [Abstract] [Full Text] [Related]

  • 18. Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy.
    Dzierlega K, Yokota T.
    Gene Ther; 2020 Sep 02; 27(9):407-416. PubMed ID: 32483212
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.